K Number
K973653
Device Name
SEEMOR - DISPLAY & PROCESSING PROGRAM EXECUTING ON PERSONAL COMPUTER SYSTEM
Date Cleared
1997-12-12

(78 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The SeeMor™ software program should be used for the display and image manipulation of multimodality diagnostic medical images.
Device Description
This medical device (SeeMor™) is a display program for viewing diagnostic medical images. The program provides the capabilities of manipulating the images being displayed with the following command options: clipping, window/level adjustment, magnification, pan, relate, add, delete, next, cine, lock, select, view, flip vertical/horizontal, set color table, orthogonal view reconstruction, cascade, tile, and reset.
More Information

Not Found

No
The description focuses on standard image manipulation tools and does not mention AI/ML capabilities.

No.
The device is described as a software program for displaying and manipulating diagnostic medical images. It does not provide any treatment or therapy to a patient.

No
The device is a display program for viewing and manipulating diagnostic medical images, not a diagnostic device itself. Its purpose is to display and process images that have already been acquired for diagnostic purposes.

Yes

The device description explicitly states "This medical device (SeeMor™) is a display program for viewing diagnostic medical images," and the intended use refers to "The SeeMor™ software program." There is no mention of accompanying hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the "display and image manipulation of multimodality diagnostic medical images." This describes a device that processes and presents existing medical images, not a device that performs tests on biological samples to diagnose conditions.
  • Device Description: The description focuses on image viewing and manipulation features (clipping, window/level, magnification, etc.). These are functions related to image processing and display, not in vitro testing.
  • No mention of biological samples: There is no mention of analyzing blood, urine, tissue, or any other biological sample, which is a core characteristic of IVDs.
  • Focus on image modalities: The input is "multimodality diagnostic medical images," which are generated by imaging equipment (like X-ray, CT, MRI, etc.), not from in vitro tests.

IVDs are devices used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device clearly falls outside of that definition.

N/A

Intended Use / Indications for Use

The SeeMor™ software program should be used for the display and image manipulation of multimodality diagnostic medical images.

Product codes (comma separated list FDA assigned to the subject device)

90 LLZ

Device Description

This medical device (SeeMor™) is a display program for viewing diagnostic medical images. The program provides the capabilities of manipulating the images being displayed with the following command options: clipping, window/level adjustment, magnification, pan, relate, add, delete, next, cine, lock, select, view, flip vertical/horizontal, set color table, orthogonal view reconstruction, cascade, tile, and reset.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

multimodality diagnostic medical images.

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

The intended use of this program was to provide the physician with a display program which would allow for the remote viewing and interpretation of medical images. This program serves merely as a display program to aid in the diagnostic interpretation of a patients' study. It does not provide any diagnostic interpretive output other than the display of the images.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The effectiveness of the program has been established in an in-house trial validation which included an evaluation of 25 patients. We contend that the method employed for the development and the final in-house trial validation results of this medical display software program (SeeMor™) have proven its safety and effectiveness.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K924178

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

ITEM I

K973653 ×973653

510(k) SUMMARY

DEC 1 2 1997

Safety and Effectiveness

1. Medical Device Establishment

Areeda Associates Ltd 516 N. Curson Avenue Los Angeles, CA 90036 Voice: (213) 653-5515 (213) 653-5514 FAX: e-mail: joe@areeda.com Contact person: Joseph Areeda or Kenneth Van Train Date Summary Prepared: September 24, 1997

2. Medical Device:

SeeMor™ - Medical Imaging Display & Processing program executing on personal computer systems.

3. Medical Device Equivalence:

MedVision™ Imaging Software developed by Evergreen Technologies, Inc., Ref. 510(k) #: K924178.

4. Device Description:

This medical device (SeeMor™) is a display program for viewing diagnostic medical images. The program provides the capabilities of manipulating the images being displayed with the following command options: clipping, window/level adjustment, magnification, pan, relate, add, delete, next, cine, lock, select, view, flip vertical/horizontal, set color table, orthogonal view reconstruction, cascade, tile, and reset.

5. Intended Use and Potential Adverse Effect on Health:

The intended use of this program was to provide the physician with a display program which would allow for the remote viewing and interpretation of

1

medical images. This program serves merely as a display program to aid in the diagnostic interpretation of a patients' study. It does not provide any diagnostic interpretive output other than the display of the images. Therefore, this program has no direct adverse effect on health since it is only providing a means of displaying the medical images for the physician. The final responsibility for interpretation of the study lies with the physician.

6. Marketing History:

There have been multiple medical device display programs marketed in the past which perform similar functions to those performed by SeeMor™. These programs are all used for the sole purpose of displaying medical images for the diagnostic interpretation by a physician. The SeeMor™ program provides a program which executes on non-propriety hardware (IBM PC or Macintosh) and we believe is substantially equivalent to the MedVision Viewer developed by Evergreen Medical Technologies K924178. To our knowledge there have been no safety problems with the MedVision Viewer medical display program which has been in the marketplace for over four years. In addition, we are not aware of any problems on any of the proprietary medical display programs which have been in the marketplace for over 20 years.

7. Conclusions:

The safety of this program has been determined through the various stages of software development which included the initial design, coding, debugging, testing, and in-house validation. The effectiveness of the program has been established in an in-house trial validation which included an evaluation of 25 patients. We contend that the method employed for the development and the final in-house trial validation results of this medical display software program (SeeMor™) have proven its safety and effectiveness.

2

Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized symbol that resembles three human figures in profile, with flowing lines suggesting movement or connection.

Food and Druq Administration 9200 Corporate Boulevard Rockville MD 20850

DEC | 2 |997

Joseph Areeda President Areeda Associates, Ltd. 516 N. Curson Ave. Los Angeles, CA 90036-1814 Re:

K973653 SeeMor™ (Image Processing System) Dated: September 24, 1997 Received: September 25, 1997 Regulatory class: Unclassified Procode: 90 LLZ

Dear Mr. Areeda:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranion.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

W.Liau Yu
Lillian Yin, Ph.D.

Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal. Ear. Nose and Throat. and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

3

510(k) Number (if known): ___K973653

Device Name: _________________________________________________________________________________________________________________________________________________________________ Personal Computers

Indications For Use:

The SeeMor™ software program should be used for the display and image manipulation of multimodality diagnostic medical images.

(PLEASE DO NOT WRITE BELOW THIS UNE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use_ 1 (Per 21 CER 801.109)

OR

Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)

Willian Y

(Division Sign-Off) (Division Sign-Off)
Division of Denductive, Abdominal, ENT, and Rachelogical Devices

510(k) Number _